No overview information available.
No background information available.
用于治疗高血压。
No associated conditions information available.
Title | Posted | Study ID | Phase | Status | Sponsor |
---|
No clinical trials found for this drug
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
---|
No FDA products found for this drug
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
---|
No EMA products found for this drug
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
---|
No HSA products found for this drug
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
---|---|---|---|---|---|---|---|---|---|
国药准字H41025055 | 片剂 | N/A | 复方 | Chemical Drug | Approved | 2020/05/14 | Domestic | ||
国药准字H31022441 | N/A | N/A | 复方 | Chemical Drug | Approved | 2002/12/18 | Domestic | ||
国药准字H31022345 | N/A | N/A | 复方 | Chemical Drug | Approved | 2002/12/18 | Domestic | ||
国药准字H42022441 | N/A | N/A | 复方 | Chemical Drug | Approved | 2003/03/25 | Domestic | ||
国药准字H34022950 | 片剂 | N/A | 复方 | Chemical Drug | Approved | 2020/06/17 | Domestic | ||
国药准字H13023586 | 片剂 | N/A | 复方 | Chemical Drug | Approved | 2020/03/27 | Domestic | ||
国药准字H44024663 | 片剂 | N/A | 复方 | Chemical Drug | Approved | 2019/09/24 | Domestic | ||
国药准字H50021858 | 片剂 | N/A | 复方 | Chemical Drug | Approved | 2020/08/24 | Domestic | ||
国药准字H22026739 | 片剂 | N/A | 复方 | Chemical Drug | Approved | 2020/03/18 | Domestic | ||
国药准字H20054081 | 片剂 | N/A | 复方 | Chemical Drug | Approved | 2020/07/24 | Domestic |
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
---|
No PPB products found for this drug
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
---|
No TGA products found for this drug